TSCAN THERAPEUTICS INC

Ticker: TCRX CUSIP: 89854M101 Class: Common Stock

Troluce Capital Advisors LLC's Holding History (CIK: 0001910321)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025

Shares 150,000 Value ($000) $218 Avg Close $1.44 Range $1.02 - $1.87

Q1 2025

Shares 83,758 Value ($000) $116 Avg Close $2.16 Range $1.28 - $3.21

Q4 2024

Shares 52,914 Value ($000) $161 Avg Close $4.53 Range $2.60 - $6.22

Q3 2024

Shares 52,914 Value ($000) $264 Avg Close $6.03 Range $4.90 - $7.89

Q2 2024

Shares 92,832 Value ($000) $543 Avg Close $7.88 Range $5.60 - $9.69

Period	Shares	Value ($000)	Average Close	Price Range
Q2 2025	150,000	$218	$1.44	$1.02 - $1.87
Q1 2025	83,758	$116	$2.16	$1.28 - $3.21
Q4 2024	52,914	$161	$4.53	$2.60 - $6.22
Q3 2024	52,914	$264	$6.03	$4.90 - $7.89
Q2 2024	92,832	$543	$7.88	$5.60 - $9.69